๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Benefit of Clopidogrel for Acute Coronary Syndrome and Percutaneous Coronary Interventions in Doubt Due to Rebound Adverse Events

โœ Scribed by David K. Cundiff


Book ID
113444898
Publisher
Elsevier Science
Year
2008
Tongue
English
Weight
35 KB
Volume
102
Category
Article
ISSN
0002-9149

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Efficacy and safety of bivalirudin in pa
โœ Dmitriy N. Feldman; Robert M. Minutello; Geoffrey Bergman; Issam Moussa; S. Chiu ๐Ÿ“‚ Article ๐Ÿ“… 2010 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 702 KB

## Abstract Objectives: This study sought to investigate if the efficacy of bivalirudin monotherapy is similar to heparin plus GP IIb/IIIa inhibition in patients with acute coronary syndromes (ACS) treated with clopidogrel following diagnostic angiography. Background: Prior trials have demonstrated